OVID THERAPEUTICS INC (OVID) Stock Balance Sheet
NASDAQ:OVID • US6904691010
Current stock price
2.01 USD
+0.06 (+3.08%)
At close:
2.41 USD
+0.4 (+19.9%)
Pre-Market:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 127.00K | 522.00K | 2.70M | 2.90M | 200.00K | |||
| Cash Equivalents | 20.48M | 25.78M | 24.34M | 42.00M | 187.60M | |||
| Marketable Securities | 4.99M | 26.77M | 78.79M | 84.10M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 3.22M | 2.87M | 3.76M | 2.40M | 2.70M | |||
| Total Current Assets | 28.82M | 55.94M | 109.60M | 131.40M | 190.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.19M | 13.23M | 14.66M | 16.10M | 200.00K | |||
| Investments And Advances | 20.91M | 20.97M | 17.63M | 5.60M | 1.60M | |||
| Intangibles | 0.00 | 100.00K | 183.00K | 200.00K | 200.00K | |||
| Other Non-Current Assets | 1.93M | 1.92M | 1.96M | 2.00M | 2.00M | |||
| Total Non-Current Assets | 35.02M | 36.23M | 34.43M | 23.90M | 4.00M | |||
| TOTAL ASSETS | 63.85M | 92.17M | 144.03M | 155.30M | 194.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.37M | 7.33M | 7.77M | 5.00M | 7.70M | |||
| Accounts Payable | 1.71M | 3.19M | 3.70M | 2.00M | 7.10M | |||
| Other Current Liabilities | 718.00K | 1.00K | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 6.80M | 10.52M | 11.47M | 7.00M | 14.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.35M | 13.42M | 44.76M | 16.00M | 0.00 | |||
| Total Non-Current Liabilities | 12.35M | 13.42M | 44.76M | 16.00M | 0.00 | |||
| TOTAL LIABILITIES | 19.15M | 23.94M | 56.23M | 23.00M | 14.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -331.38M | -304.30M | -277.87M | -225.50M | -171.40M | |||
| Additional Paid In Capital | 376.13M | 372.49M | 365.59M | 357.80M | 351.00M | |||
| Common Shares | 71.00K | 71.00K | 70.70K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -126.00K | -35.00K | 700.00 | 0.00 | N/A | |||
| Shares Outstanding | 71.15M | 71.01M | 70.69M | 70.50M | 70.40M | |||
| Tangible Book Value per Share | 0.63 | 0.96 | 1.24 | 1.87 | 2.55 | |||
| Total Shareholders' Equity | 44.70M | 68.23M | 87.80M | 132.30M | 179.70M | |||
| TOTAL LIABILITIES AND EQUITY | 63.85M | 92.17M | 144.03M | 155.30M | 194.50M | |||
| Statistics | ||||||||
| Current Ratio | 4.24 | 5.32 | 9.55 | 18.77 | 12.87 | |||
| Return On Assets (ROA) | -56.90% | -28.68% | -36.34% | -34.90% | 61.59% | |||
| Return On Equity (ROE) | -81.28% | -38.74% | -59.61% | -40.97% | 66.67% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 54.60% | |||
All data in USD , ROIC based on taxRate of 0.21